Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annals of Cancer Research and Therapy is Scopus-indexed (Q4, CiteScore 0.8). Published by PJD Publications Ltd.
Checked against the index lists dated .
ISSN 1344-6835Verify ISSN ↗
Publisher: PJD Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 350 / 428 | 18th | Q4 |
| Pharmacology (medical) | 233 / 278 | 16th | Q4 |
| Cancer Research | 209 / 233 | 10th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present (also 2000, 1992–1998), best quartile Q4, CiteScore 0.8.
Annals of Cancer Research and Therapy is Q4 in Oncology (rank 350 of 428), Q4 in Pharmacology (medical) (rank 233 of 278) and Q4 in Cancer Research (rank 209 of 233), by CiteScore 2025.
Annals of Cancer Research and Therapy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q4, 18th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.205, quartile Q3, with an H-index of 7.
Annals of Cancer Research and Therapy is published by PJD Publications Ltd. Its ISSN is 1344-6835.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annals of Cancer Research and Therapy has an h-index of 10 and a 2-year mean of 0.4 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #346 of 424 Scopus journals in Oncology.
Annals of Cancer Research and Therapy published 6 papers in 2025; its busiest recent year was 2020 with 31. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 74 research articles (2021–2026), authors are most often from Japan (39.2%), Iran (13.5%) and Morocco (8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.